Omar Rabeea F, Trottier Sylvie, Brousseau Ghislain, Ouellet Christine, Danylo Alexis, Ong Thomas, Bergeron Michel G
Centre de Recherche en Infectiologie de l'Université Laval, Quebec QC.
Département de Radiologie, Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Quebec QC.
J Obstet Gynaecol Can. 2014 Jan;36(1):42-50. doi: 10.1016/S1701-2163(15)30682-4.
Conventional vaginal applicators with a single apical hole do not distribute vaginal formulations homogenously and do not cover the entire vaginal and cervical mucosa. To overcome this problem and offer women further protection against vaginal infections, we designed a unique vaginal applicator with multiple apical and lateral holes. We have previously shown that the new applicator distributes an investigational vaginal gel homogenously over the entire vaginal and cervical mucosa. In this study, we investigated (using MRI) whether the new applicator works as well with marketed vaginal gels and creams.
Eighteen women participated in the study and six vaginal gels and creams were tested. Each woman used a marketed vaginal product with its own commercial applicator (CA) once and with our universal vaginal applicator (UVA) once to deliver the same product. The applications were separated by a one-week period. Pelvic MRI was performed immediately after vaginal application to evaluate the product's distribution and mucosal coverage.
Immediately after application of the vaginal product, the UVA homogenously distributed the six products (3 gels and 3 creams) over the entire vaginal and cervical mucosa. On the other hand, the tested CA delivered four products (3 gels and 1 cream) mainly to the cervix and the upper vagina, but not to the mid and lower vagina; for the other two creams, the distribution was similar to that of UVA. Furthermore, the UVA received the highest acceptability score.
The UVA can be used to deliver different vaginal gel and cream products homogenously throughout the vagina. This was the first time the UVA had been tested with marketed vaginal gels and creams. This applicator, giving uniform mucosal coverage and being highly acceptable, may help women to better protect themselves against sexually transmitted infections.
传统的单顶端孔阴道给药器不能均匀地分布阴道制剂,也不能覆盖整个阴道和宫颈黏膜。为克服这一问题并为女性提供针对阴道感染的进一步保护,我们设计了一种独特的具有多个顶端和侧面孔的阴道给药器。我们之前已经表明,这种新型给药器能将一种研究用阴道凝胶均匀地分布在整个阴道和宫颈黏膜上。在本研究中,我们(使用磁共振成像)调查了这种新型给药器对于市售阴道凝胶和乳膏的效果是否同样良好。
18名女性参与了该研究,测试了6种阴道凝胶和乳膏。每位女性分别使用一次市售阴道产品及其自带的商用给药器(CA),并使用一次我们的通用阴道给药器(UVA)来递送相同的产品。两次给药间隔一周。在阴道给药后立即进行盆腔磁共振成像,以评估产品的分布和黏膜覆盖情况。
阴道产品给药后,UVA能将6种产品(3种凝胶和3种乳膏)均匀地分布在整个阴道和宫颈黏膜上。另一方面,测试的CA将4种产品(3种凝胶和1种乳膏)主要递送至宫颈和阴道上段,而未递送至阴道中段和下段;对于另外两种乳膏,其分布与UVA相似。此外,UVA获得了最高的可接受性评分。
UVA可用于在整个阴道内均匀地递送不同的阴道凝胶和乳膏产品。这是UVA首次用于测试市售阴道凝胶和乳膏。这种给药器能提供均匀的黏膜覆盖且高度可接受,可能有助于女性更好地保护自己免受性传播感染。